Publications by authors named "Maria Ardanaz"

Claim this Profile
P
Profound Impact of Local Climatic Conditions on IgE Sensitization Profiles: Evidence from Argentine Cities.
Eszter Sarzsinszky, Paola Smaldini, Marcela Chinigo, María Ardanaz, Pablo Benítez

Int J Mol Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of deletions.
Anna Puiggros, Rosa Collado, Maria José Calasanz, Margarita Ortega, Neus Ruiz-Xivillé, María Teresa Ardanaz

Oncotarget· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.
Xavier Calvo, Leonor Arenillas, Elisa Luño, Leonor Senent, Montserrat Arnan, María Teresa Ardanaz

Mod Pathol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.
Leonor Arenillas, Xavier Calvo, Elisa Luño, Leonor Senent, Esther Alonso, María Teresa Ardanaz

J Clin Oncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: a population-based study.
David Valcárcel, Guillermo Sanz, Margarita Ortega, Benet Nomdedeu, Elisa Luño, María Teresa Ardanaz

Lancet Haematol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.
Anna Puiggros, Marta Venturas, Marta Salido, Gonzalo Blanco, Concepción Fernandez-Rodriguez, María Teresa Ardanaz

Genes Chromosomes Cancer· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: review of 5,654 patients with an evaluable karyotype.
Dolors Costa, Concha Muñoz, Ana Carrió, Meritxell Nomdedeu, Xavier Calvo

Genes Chromosomes Cancer· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome.
Judit Sánchez-Castro, Víctor Marco-Betés, Xavier Gómez-Arbonés, Leonor Arenillas, David Valcarcel, María T Ardanaz

Leuk Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytogenetic risk stratification in chronic myelomonocytic leukemia.
Esperanza Such, José Cervera, Dolors Costa, Francesc Solé, Teresa Vallespí, María T Ardanaz

Haematologica· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.
Blanca Espinet, Itziar Salaverria, Sílvia Beà, Neus Ruiz-Xivillé, Olga Balagué, María Teresa Ardanaz

Genes Chromosomes Cancer· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.
Anna Enjuanes, Yolanda Benavente, Francesc Bosch, Idoia Martín-Guerrero, Dolors Colomer, Maria T Ardanaz

Cancer Res· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas.
José Ignacio Martín-Subero, María Dolores Odero, Roberto Hernandez, Juan Cruz Cigudosa, Xabier Agirre, María T Ardanaz

Genes Chromosomes Cancer· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases.
José L Vizmanos, Roberto Hernández, María J Vidal, María J Larráyoz, María D Odero, María T Ardanaz

Hematol J· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission of acute monocytic leukemia, secondary to treatment with epipodophyllotoxins, in a patient with t(8;16)(p11;p13) and MYST3-CREBBP fusion.
José L Vizmanos, María J Larráyoz, Iria Vázquez, María D Odero, Roberto Hernández, María T Ardanaz

Cancer Genet Cytogenet· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis